Story perspectives

Breakthrough Antibody Therapy Transforms Stem Cell Transplants

11/9/2025

45 7

Summary

Story summary

Stanford Medicine researchers report an antibody therapy enabling Fanconi anemia stem cell transplants without toxic chemotherapy or radiation.
In a phase 1 trial, therapy treated three children, including Ryder Baker, who now thrives post-transplant.
Researchers led by Dr. Agnieszka Czechowicz aim to expand method to other genetic disorders and elderly cancer patients.
The study shows promise in reducing complications from traditional transplant protocols and outlines next-generation treatments to improve outcomes.

1 of 1

Story summary

Stanford Medicine researchers report an antibody therapy enabling Fanconi anemia stem cell transplants without toxic chemotherapy or radiation.
In a phase 1 trial, therapy treated three children, including Ryder Baker, who now thrives post-transplant.
Researchers led by Dr. Agnieszka Czechowicz aim to expand method to other genetic disorders and elderly cancer patients.
The study shows promise in reducing complications from traditional transplant protocols and outlines next-generation treatments to improve outcomes.